Reduced Acute Graft-Versus Host Disease Incidence In Patients Receiving Anti-T Lymphocyte Globulin In Comparison To Anti-Thymocyte Globulin For The Prophylaxis Of Graft-Versus-Host Disease After Allo-Hsct

BONE MARROW TRANSPLANTATION(2021)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要